首页 | 本学科首页   官方微博 | 高级检索  
     

易瑞沙治疗42例化疗失败的晚期肺腺癌的临床观察
引用本文:马惠文,余慧青,邵江河. 易瑞沙治疗42例化疗失败的晚期肺腺癌的临床观察[J]. 重庆医学, 2011, 40(24): 2413-2414. DOI: 10.3969/j.issn.1671-8348.2011.24.008
作者姓名:马惠文  余慧青  邵江河
作者单位:重庆市肿瘤研究所、肿瘤医院肿瘤内科,400030
摘    要:目的 观察易瑞沙单药治疗化疗失败的晚期肺腺癌的疗效和不良反应.方法 42例化疗失败的晚期肺腺癌患者口服易瑞沙250 mg,1次/d,直至病情进展或出现严重不良反应.结果 42例患者中完全缓解(CR)2例,占4.76%,部分缓解(PR)25例,占59.52%,稳定(SD)10例,占23.81%,进展(PD)5例,占11....

关 键 词:治疗  易瑞沙  肺腺癌

Effects of iressa on 42 cases of chemotherapy failed advanced lung adenocarcinoma
Ma Huiwen,Yu Huiqing,Shao Jianghe. Effects of iressa on 42 cases of chemotherapy failed advanced lung adenocarcinoma[J]. Chongqing Medical Journal, 2011, 40(24): 2413-2414. DOI: 10.3969/j.issn.1671-8348.2011.24.008
Authors:Ma Huiwen  Yu Huiqing  Shao Jianghe
Affiliation:Ma Huiwen,Yu Huiqing,Shao Jianghe(Department of Tumor,Cancer Research Institute of Chongqing,Chongqing 400030,China)
Abstract:Objective To evaluate the antitumor efficacy and adverse effects of single-drug iressa in treatment of advanced lung adenocarcinoma patients who underwent failure during in previous chemotherapy.Methods 42 patients with chemotherapy failed advanced lung adenocarcinoma were given iressa 250 mg once a day until disease progression or occurrence of intolerable toxic reaction.Results Among 42 cases,2 cases(4.76%) were in CR,25 cases(59.52%) were in PR,10 cases(23.81%) were in SD,and 5 cases(11.90%) were in PD;t...
Keywords:therapy  iressa  lung adenocarcinoma  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号